Bio Protocol vs Mitosis — how do they compare? Bio Protocol trades at Rp443.9 (market cap Rp1,01T, Rp176,29M 24h volume), while Mitosis trades at Rp453.09 (market cap Rp81,83M, Rp76,1M 24h volume). The key difference: Bio Protocol is far larger — about 12342.7× Mitosis's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Mitosis for 20 Days on average.
| BIO | MITO | |
|---|---|---|
Market Cap | Rp1,01T | Rp81,83M |
Volume (24h) | Rp176,29M | Rp76,1M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 18 Days | 20 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
MITO is trading at Rp429.77 with a market cap of Rp77.87M, showing bullish technical signals across moving averages and oscillators. The token is currently trading between support at Rp364 and resistance at Rp487, with RSI indicators suggesting overbought conditions. Recent news indicates strategic developments in the ecosystem, though specific crypto protocol updates are limited.
Overall outlook remains cautiously optimistic due to strong technical momentum, but investors should be aware of overbought RSI levels and limited fundamental updates. Key risks include typical crypto volatility and liquidity constraints given the modest market capitalization.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →